Skip to main content
OpenTrials
Completed

NCT Number: NCT02628158

Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane

Fundus autofluorescence (FAF) at the macula originates from hyperfluorescence from retinal pigment epithelium (RPE) and blockage of hyperfluorescence by macular pigment. Investigators evaluate whether presence of FAF may correlate to the postoperative visual outcome for epiretinal membrane.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–90 year

Study type

Observational

Primary location

Kyorin Eye Center

Mitaka, Tokyo, 181-8611, Japan

About this study

92 eyes with epiretinal membrane were performed vitreous surgery, epiretinal membrane removal and internal limiting membrane (ILM) peeling. Presence of hyperfluorescence in FAF at the macular area and best-corrected visual acuity (BCVA) was evaluated preoperatively and at postoperative 1, 3, and 6 months with ultra-wide angle imaging.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The inclusion criteria were patients who underwent vitrectomy and internal limiting membrane removal for epiretinal membrane and had followed for more than 6 months.

Exclusion criteria

  • The patients with follow-up less than 6 months.

Treatment and study plan

Vitrectomy with internal limiting membrane removal

Procedure

Vitrectomy with removal of epiretinal membrane and internal limiting membrane

Primary outcomes

  1. Visual acuity before and after surgery

    Time frame: Changes from baseline to 1, 3, 6 months

    Vision

Secondary outcomes

  1. Presence of fluids autofluorescence at the macular area

    Time frame: Changes from baseline up to 6 months

    Fundus autofluorescence

Sponsors and collaborators

Lead sponsor

Kyorin University

Other

Registry information

Official study title

Correlation of Postoperative Vision and Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane

Important dates

Study start
2013
Primary completion
2015
Study completion
2015
First posted
Dec 11, 2015
Registry last updated
Dec 11, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.